Skip to main content

Revolution Medicines, Inc.

RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001628171

In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.

Other share classesRVMDW

13F holders, Q1 2025

Institutional positions in Revolution Medicines, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
284
+9 vs. Q4 2024
Shares held
192.5M
+9.70M (+5.3%) vs. Q4 2024
Total value
$6.83B
−$1.17B (−14.6%) vs. Q4 2024
New holders
50
97 more added
Sold out
41
88 more reduced

6 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 284 institutions
Q1 2021: 128 institutionsQ2 2021: 130 institutionsQ3 2021: 114 institutionsQ4 2021: 117 institutionsQ1 2022: 126 institutionsQ2 2022: 135 institutionsQ3 2022: 142 institutionsQ4 2022: 135 institutionsQ1 2023: 152 institutionsQ2 2023: 139 institutionsQ3 2023: 168 institutionsQ4 2023: 184 institutionsQ1 2024: 210 institutionsQ2 2024: 223 institutionsQ3 2024: 255 institutionsQ4 2024: 281 institutionsQ1 2025: 284 institutionsQ2 2025: 308 institutionsQ3 2025: 323 institutionsQ4 2025: 387 institutionsQ1 2026: 514 institutionsQ2 2026: 693 institutions
Value heldQ1 2025: $6.83B
Q1 2021: $3.05BQ2 2021: $2.23BQ3 2021: $1.99BQ4 2021: $1.85BQ1 2022: $1.89BQ2 2022: $1.49BQ3 2022: $1.74BQ4 2022: $2.10BQ1 2023: $2.34BQ2 2023: $2.99BQ3 2023: $3.11BQ4 2023: $4.59BQ1 2024: $5.18BQ2 2024: $6.54BQ3 2024: $7.74BQ4 2024: $8.45BQ1 2025: $6.83BQ2 2025: $7.02BQ3 2025: $8.96BQ4 2025: $15.9BQ1 2026: $19.1BQ2 2026: $40.1B
Institutions holding RVMD and their total value by quarter
QuarterHoldersValue
Q2 2026693$40.1B
Q1 2026514$19.1B
Q4 2025387$15.9B
Q3 2025323$8.96B
Q2 2025308$7.02B
Q1 2025284$6.83B
Q4 2024281$8.45B
Q3 2024255$7.74B
Q2 2024223$6.54B
Q1 2024210$5.18B
Q4 2023184$4.59B
Q3 2023168$3.11B
Q2 2023139$2.99B
Q1 2023152$2.34B
Q4 2022135$2.10B
Q3 2022142$1.74B
Q2 2022135$1.49B
Q1 2022126$1.89B
Q4 2021117$1.85B
Q3 2021114$1.99B
Q2 2021130$2.23B
Q1 2021128$3.05B

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q4 2024.

Institutions holding RVMD in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Qube Research & Technologies Ltd183,140$6.48M0.01%−47,705−20.7%Reduced
Marshall Wace, LLP187,188$6.62M0.01%−1,317,613−87.6%Reduced
Invesco Ltd.190,259$6.73M0.00%+72,607+61.7%Added
Comerica Bank193,719$6.85M0.03%+193,267+42,758.2%Added
Alliancebernstein L.P.194,078$6.86M0.00%−40,851−17.4%Reduced
California Public Employees Retirement System212,915$7.53M0.01%−55,374−20.6%Reduced
Avidity Partners Management LP213,000$7.53M1.55%−233,200−52.3%Reduced
Edgestream Partners, L.P.215,717$7.63M0.26%+207,938+2,673.1%Added
HSBC Holdings PLC220,188$7.78M0.01%−49,106−18.2%Reduced
Decheng Capital LLC226,000$7.99M2.24%00.0%Unchanged
Manufacturers Life Insurance Company, The240,095$8.49M0.01%+2,556+1.1%Added
Bessemer Group Inc243,571$8.61M0.02%+130.0%Added
Susquehanna International Group, LLP244,053$8.63M0.01%+97,865+66.9%Added
Integral Health Asset Management, LLC250,000$8.84M0.98%−300,000−54.5%Reduced
Rhumbline Advisers257,150$9.09M0.01%+5,685+2.3%Added
WCM Investment Management, LLC245,997$9.19M0.02%+88,520+56.2%Added
Russell Investments Group, Ltd.276,230$9.77M0.01%+271,987+6,410.3%Added
Swiss National Bank276,531$9.78M0.01%+46,600+20.3%Added
Barclays PLC278,451$9.85M0.00%−130,163−31.9%Reduced
UBS Asset Management Americas Inc300,196$10.6M0.00%+37,345+14.2%Added
Raymond James Financial Inc303,617$10.7M0.00%−17,994−5.6%Reduced
MPM Oncology Impact Management LP317,083$11.2M1.93%+3,266+1.0%Added
StemPoint Capital LP318,782$11.3M3.60%+125,247+64.7%Added
Voya Investment Management LLC319,491$11.3M0.01%+3,463+1.1%Added
TD Asset Management Inc325,876$11.5M0.01%+44,490+15.8%Added
Jane Street Group, LLC337,402$11.9M0.02%+273,471+427.8%Added
Victory Capital Management Inc337,881$11.9M0.01%−92,581−21.5%Reduced
First Turn Management, LLC340,109$12.0M2.42%−63,806−15.8%Reduced
Lord, Abbett & Co. LLC367,630$13.0M0.05%−1,611,090−81.4%Reduced
Eventide Asset Management, LLC372,229$13.2M0.26%00.0%Unchanged
Dimensional Fund Advisors LP373,754$13.2M0.00%−14,021−3.6%Reduced
Checkpoint Capital L.P.392,011$13.9M7.61%+182,011+86.7%Added
Adage Capital Partners GP, L.L.C.394,000$13.9M0.03%−256,000−39.4%Reduced
Ensign Peak Advisors, Inc427,466$15.1M0.03%+122,294+40.1%Added
Bank of America Corp446,562$15.8M0.00%+45,519+11.4%Added
Caligan Partners LP465,000$16.4M3.43%+465,000New
Nuveen, LLC477,860$16.9M0.01%+477,860New
UBS Group AG482,107$17.0M0.00%+182,324+60.8%Added
MIC Capital Management UK LLP508,569$18.0M3.66%00.0%Unchanged
BNP Paribas Arbitrage, SA524,428$18.5M0.01%+276,102+111.2%Added
Siren, L.L.C.563,755$19.9M1.12%−7,793−1.4%Reduced
Bank of New York Mellon Corp582,721$20.6M0.00%+13,706+2.4%Added
Citigroup Inc609,388$21.5M0.02%+340,934+127.0%Added
Candriam Luxembourg S.C.A.655,134$23.2M0.15%−1,606−0.2%Reduced
DAFNA Capital Management LLC656,176$23.2M6.58%+25,000+4.0%Added
Finepoint Capital LP691,260$24.4M4.12%−19,000−2.7%Reduced
American Century Companies Inc741,860$26.2M0.02%+100,214+15.6%Added
Pictet Asset Management Holding SA747,560$26.4M0.03%+34,964+4.9%Added
Polar Capital Holdings Plc750,665$26.5M0.16%00.0%Unchanged
Frazier Life Sciences Management, L.P.997,455$35.3M1.61%00.0%Unchanged
Westfield Capital Management Co LP1,064,046$37.6M0.18%+1,058,247+18,248.8%Added
Morgan Stanley1,255,687$44.4M0.00%+397,409+46.3%Added
Rock Springs Capital Management LP1,281,640$45.3M2.59%+68,383+5.6%Added
Boxer Capital Management, LLC1,317,977$46.6M14.02%−2,961,487−69.2%Reduced
Norges Bank1,403,528$49.6M0.01%−338,511−19.4%Reduced
Ameriprise Financial Inc1,490,658$52.7M0.01%−136,190−8.4%Reduced
Northern Trust Corp1,534,757$54.3M0.01%−5,321−0.3%Reduced
Logos Global Management LP1,600,000$56.6M10.06%+150,000+10.3%Added
T. Rowe Price Investment Management, Inc.1,673,429$59.2M0.04%+1,673,429New
Hood River Capital Management LLC1,717,048$60.7M1.04%+38,614+2.3%Added
Charles Schwab Investment Management Inc1,930,468$68.3M0.01%−6460.0%Reduced
Goldman Sachs Group Inc2,164,501$76.5M0.01%−465,651−17.7%Reduced
Lunate Capital Ltd2,196,200$77.7M45.36%+2,196,200New
AH Capital Management, L.L.C.2,748,523$97.2M13.87%00.0%Unchanged
Deerfield Management Company, L.P. (Series C)3,317,332$117.3M2.33%+59,000+1.8%Added
Holocene Advisors, LP3,691,744$130.5M0.39%+695,034+23.2%Added
Casdin Capital, LLC3,697,933$130.8M10.68%−1,3500.0%Reduced
JPMorgan Chase & Co3,702,909$130.9M0.01%−126,440−3.3%Reduced
Woodline Partners LP3,887,036$137.4M0.89%+1,3230.0%Added
Alphabet Inc.4,133,277$146.2M9.27%00.0%Unchanged
Geode Capital Management, LLC4,142,414$146.5M0.01%+56,215+1.4%Added
Bellevue Group AG4,374,300$154.7M3.47%−12,600−0.3%Reduced
BVF Inc4,982,384$176.2M7.18%+801,205+19.2%Added
Price T Rowe Associates Inc5,599,642$198.0M0.02%−266,320−4.5%Reduced
State Street Corp5,804,919$205.3M0.01%+13,167+0.2%Added
Paradigm Biocapital Advisors LP6,178,111$218.5M10.06%−375,000−5.7%Reduced
FMR LLC7,535,771$266.5M0.02%+793,688+11.8%Added
Nextech Invest, Ltd.7,601,087$268.8M62.46%+7,601,087New
Baker Bros. Advisors LP7,936,972$280.7M3.11%00.0%Unchanged
Janus Henderson Group PLC10,190,071$380.6M0.21%+706,072+7.4%Added
Wellington Management Group LLP11,787,921$416.8M0.08%+966,230+8.9%Added
Farallon Capital Management, L.L.C.13,534,692$478.6M2.58%+286,000+2.2%Added
BlackRock, Inc.14,692,392$519.5M0.01%−27,156−0.2%Reduced
Vanguard Group Inc16,612,035$587.4M0.01%−484,420−2.8%Reduced
Balyasny Asset Management LLC0$00.00%−1,302,848−100.0%Sold out
Ghisallo Capital Management LLC0$00.00%−257,100−100.0%Sold out
Empowered Funds, LLC0$00.00%−132,679−100.0%Sold out
Great Lakes Advisors, LLC0$00.00%−110,973−100.0%Sold out
Pamalican Asset Management Ltd0$00.00%−75,000−100.0%Sold out
Caption Management, LLC0$00.00%−72,795−100.0%Sold out
Maven Securities LTD0$00.00%−65,000−100.0%Sold out
Altium Capital Management LP0$00.00%−60,000−100.0%Sold out
Brevan Howard Capital Management LP0$00.00%−41,884−100.0%Sold out
Polar Asset Management Partners Inc.0$00.00%−34,600−100.0%Sold out
Bryce Point Capital, LLC0$00.00%−18,479−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−14,831−100.0%Sold out
LPL Financial LLC0$00.00%−10,318−100.0%Sold out
Wingate Wealth Advisors, Inc.0$00.00%−10,000−100.0%Sold out
Cambridge Investment Research Advisors, Inc.0$00.00%−8,358−100.0%Sold out
JGP Global Gestao de Recursos Ltda.0$00.00%−7,704−100.0%Sold out